# A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily

> **NCT04983589** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 230 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** Pilocarpine HCl
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT04983589
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-02
- **Primary completion:** 2022-02-11
- **Final completion:** 2022-02-11
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2023-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04983589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04983589, "A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04983589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*